Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Hengrui Pharmaceuticals' Lung Cancer Drug Included in China's Breakthrough Therapy Designation List
9+ hour, 5+ min ago (69+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Jiangsu Hengrui Pharmaceuticals Co.,Ltd Hengrui Pharmaceuticals' Lung Cancer…...
Telix Pharmaceuticals Says US FDA Approves New Drug Application for Brain Cancer Imaging Drug
12+ hour, 41+ min ago (42+ words) marketscreener.com Biotechnology & Medical Research Telix Pharmaceuticals Says US FDA Approves New Drug Application for Brain Cancer Imaging Drug Published on 09/13/2026 at 07:10 pm EDT...
Exelixis FDA Delay Moves Zanzalintinib Decision to March 2027
2+ day, 1+ hour ago (10+ words) TechStock²...
Cyclosporiasis outbreak that sickened tens of thousands officially over, CDC says
2+ day, 11+ hour ago (549+ words) The massive diarrhea-causing parasitic outbreak that sickened tens of thousands of people across 21 states over the summer has ended, though officials continue to investigate the cause of contamination. On Friday, the U.S. Centers for Disease Control and Prevention declared the cyclosporiasis…...
Scholar Rock wins FDA approval for first drug to target SMA muscle loss
2+ day, 12+ hour ago (214+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
US FDA approves Scholar Rock’s muscle weakness drug
2+ day, 14+ hour ago (80+ words) Sept 11 (Reuters) - The U.S. Food and Drug Administration on Friday approved Scholar Rock's therapy to treat a rare genetic condition that causes muscle weakness. (Reporting by Sneha S K in Bengaluru; Editing by Tasim Zahid)... US FDA approves Scholar…...
US Declares End of Largest Recorded Cyclosporiasis Outbreak
2+ day, 21+ hour ago (34+ words) US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education....
Astrazeneca’s breast cancer drug fails late-stage trial
2+ day, 14+ hour ago (77+ words) Sept 11 (Reuters) - AstraZeneca said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Tasim Zah... Astrazeneca’s breast cancer drug fails late-stage…...
US FDA pauses new enrollment in Biohaven’s epilepsy drug trials
3+ day, 17+ hour ago (293+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug after rodent findings, sending its shares down more than 15% in early trading. • The U....
Indonesian wildfires cause respiratory infections to double in a week, health ministry says
3+ day, 19+ hour ago (19+ words) NST Online What To Read Next...